IP Library Granted Patent US 10,898,499
Granted Patent B2
US 10,898,499 · App. 16/527,171 · Granted Jan 26, 2021

C17-heteroaryl derivatives of oleanolic acid and methods of use thereof

Inventors: Xin Jiang (Coppell, TX); Christopher F. Bender (Garland, TX); Melean Visnick (Irving, TX)
Assignee: REATA PHARMACEUTICALS, INC.
A61K31/58C07D271/06C07D271/10C07J63/008
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,898,499
App. No.
16/527,171
Granted
Jan 26, 2021
Kind
B2
Abstract

Disclosed herein are novel C17-heteroaryl derivatives of oleanolic acid, including those of the formula: wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds. Methods and intermediates useful for making the compounds, and methods of using the compounds, for example, as antioxidant inflammation modulators, and compositions thereof are also provided.

Claims (50)

1. A compound of the formula:

wherein:

n is 0;

X 1 is —O— or —NH—;

X 2 is ═O or ═NH; and

Y is:

hydrogen, hydroxy, halo, amino, or cyano or —NCO; or

alkyl (C≤8) , alkenyl (C≤8) , alkynyl (C≤8) , aryl (C≤12) , aralkyl (C≤12) , heteroaryl (C≤8) , heterocycloalkyl (C≤12) , acyl (C≤12) , alkoxy (C≤8) , aryloxy (C≤12) , acyloxy (C≤8) , alkylamino (C≤8) , dialkylamino (C≤8) , arylamino (C≤8) , aralkylamino (C≤8) , alkylthio (C≤8) , acylthio (C≤8) , alkylsulfonylamino (C≤8) , or substituted versions of any of these groups;

or a salt thereof.

2. The compound of claim 1 , wherein X 1 is —NH— and X 2 is ═O.

3. The compound of claim 1 , wherein X 1 is —O— and X 2 is ═NH.

4. The compound of claim 1 , wherein Y is —H.

5. The compound of claim 1 , wherein Y is alkyl (C≤4) .

6. The compound of claim 5 , wherein Y is methyl, n-propyl, isopropyl or cyclopropyl.

7. The compound of claim 1 , wherein Y is substituted alkyl (C≤4) .

8. The compound of claim 7 , wherein Y is methoxymethyl.

9. The compound of claim 1 , further defined as:

or a salt thereof.

10. A method of making a compound of formula I:

or a pharmaceutically acceptable salt thereof, wherein:

n is 0-3;

Ar is heteroarenediyl (C≤8) or a substituted version thereof; and

Y is:

hydrogen, hydroxy, halo, amino, or cyano or —NCO; or

alkyl (C≤8) , alkenyl (C≤8) , alkynyl (C≤8) , aryl (C≤12) , aralkyl (C≤12) , heteroaryl (C≤8) , heterocycloalkyl (C≤12) , acyl (C≤12) , alkoxy (C≤8) , aryloxy (C≤12) , acyloxy (C≤8) , alkylamino (C≤8) , dialkylamino (C≤8) , arylamino (C≤8) , aralkylamino (C≤8) , alkylthio (C≤8) , acylthio (C≤8) , alkylsulfonylamino (C≤8) , or substituted versions of any of these groups;

comprising obtaining a compound of formula Ia:

or a salt thereof, wherein:

n is 0-3;

X 1 is —O— or —NH—;

X 2 is ═O or ═NH; and

Y is:

hydrogen, hydroxy, halo, amino, or cyano or —NCO; or

alkyl (C≤8) , alkenyl (C≤8) , alkynyl (C≤8) , aryl (C≤12) , aralkyl (C≤12) , heteroaryl (C≤8) , heterocycloalkyl (C≤12) , acyl (C≤12) , alkoxy (C≤8) , aryloxy (C≤12) , acyloxy (C≤8) , alkylamino (C≤8) , dialkylamino (C≤8) , arylamino (C≤8) , aralkylamino (C≤8) , alkylthio (C≤8) , acylthio (C≤8) , alkylsulfonylamino (C≤8) , or substituted versions of any of these groups; and

reacting the compound of formula Ia under conditions suitable to form the compound of formula I, wherein the conditions comprise reacting the compound of formula Ia with an acid.

11. The method of claim 10 , wherein the acid is p-TsOH.

12. The method of claim 10 , wherein the conditions comprise heating the compound of formula I in a solvent.

13. The method of claim 12 , wherein the solvent is toluene.

14. The method of claim 12 , further comprising heating the mixture of the compound of formula I in the solvent to reflux.

15. The method of claim 10 , wherein the conditions comprise applying microwave radiation to a mixture comprising the compound of formula Ia and a solvent.

16. The method of claim 10 , wherein n is 0.

17. The method of claim 10 , wherein n is 1.

18. The method of claim 10 , wherein X 1 is —NH— and X 2 is ═O.

19. The method of claim 10 , wherein X 1 is —O— and X 2 is ═NH.

20. The method of claim 10 , wherein Y is —H.

21. The method of claim 10 , wherein Y is alkyl (C≤4) .

22. The method of claim 21 , wherein Y is methyl, n-propyl, isopropyl or cyclopropyl.

23. The method of claim 10 , wherein Y is substituted alkyl (C≤4) .

24. The method of claim 23 , wherein Y is methoxymethyl.

25. The method of claim 10 , wherein the compound of formula Ia is further defined as:

or a salt thereof.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Apr 9, 2025
From: BIOPHARMA CREDIT PLC
To: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
Reel/Frame 070793/0130 →
RELEASE OF SECURITY INTEREST Recorded Apr 9, 2025
From: BIOPHARMA CREDIT PLC
To: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
Reel/Frame 070793/0228 →
AMENDED AND RESTATED PATENT SECURITY AGREEMENT Recorded Jul 12, 2023
From: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 064264/0557 →
PATENT SECURITY AGREEMENT Recorded May 18, 2023
From: REATA PHARMACEUTICALS HOLDINGS, LLC; REATA PHARMACEUTICALS GLOBAL, INC.; REATA PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 063697/0461 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 31, 2019
From: JIANG, XIN; BENDER, CHRISTOPHER F.; VISNICK, MELEAN
To: REATA PHARMACEUTICALS, INC.
Reel/Frame 049912/0221 →
Continuity (6)
Continuation 15861241 · Jan 3, 2018
Division 15349086 · Nov 11, 2016
Division 14566827 · Dec 11, 2014
Continuation In Part 14022843 · Sep 10, 2013
Provisional Application 61699199 · Sep 10, 2012
Related Publication 20200129530A1 · Apr 30, 2020
Cited By (1)
US 12,545,701